Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (clinicaltrials.gov) - Oct 23, 2026 - P=N/A | N=300 | Active, not recruiting | Sponsor: Chinese University of Hong Kong | Trial completion date: Mar 2026 ➔ Mar 2028 | Trial primary completion date: Dec 2025 ➔ Dec 2027
Trial completion date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|